BLU — BELLUS Health Income Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMid Cap
- $1.87bn
- $1.56bn
- $0.02m
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.027 | 0.027 | 0.015 | 0.016 | 0.016 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.67 | 25.8 | 33 | 73.3 | 77.9 |
Operating Profit | -7.64 | -25.7 | -32.9 | -73.3 | -77.9 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.01 | -26 | -31.8 | -71.4 | -76 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.01 | -26 | -31.8 | -71.2 | -76.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.01 | -26 | -31.8 | -71.2 | -76.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.01 | -26 | -31.8 | -71.2 | -76.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.209 | -0.548 | -0.538 | -0.898 | -0.66 |